In the dPCR assay, KRAS G12/G13 mutations were found in the PDA from 10 patients, including IPMN-associated pancreatic cancers; 1 PDA patient exhibited mutant KRAS Q61H. Here, KRAS is linked to Patent ductus arteriosus.